Companies › CNTX
CONTEXT THERAPEUTICS INC (CNTX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001842952 · EDGAR filings · Updated 2026-07-27
CONTEXT THERAPEUTICS INC (CNTX) has reported institutional ownership of 80.7%, with 59 institutional managers holding positions valued at $194.3M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-27 — SCHEDULE 13G filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-06-26 — Insider transaction reported (Form 4)
- 2026-06-26 — Insider transaction reported (Form 4)
- 2026-06-26 — Insider transaction reported (Form 4)
- 2026-06-26 — Insider transaction reported (Form 4)
- 2026-06-26 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CONTEXT THERAPEUTICS INC has 59 institutional holders and institutional ownership of 80.7%.
Insider activity
Insiders reported 3 transactions (3 buys, 0 sells) across 3 reporting insiders, with a net reported value of $107.2K.
Data flags from SEC filings
Related companies
OPUS GENETICS INC (IRD) · OCUGEN INC COM (OCGN) · ATRIUM THERAPEUTICS INC (RNA) · INHIBIKASE THERAPEUTICS INC (IKT) · ALECTOR INC (ALEC) · ALX ONCOLOGY HLDGS INC (ALXO)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.